Applied Therapeutics (APLT) Financials

$0.10

$0.00 (0.00%)

As on 04-Feb-2026 09:30EDT

Market cap

$15 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

7.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	1.00	0.46	9.99	10.66	--	--
Cost of Revenue	17.76	48.74	53.91	0.44	0.42	0.38
Gross Profit	-16.76	-48.29	-43.91	-0.44	-0.42	-0.38
Operating Expenses	81.64	56.01	20.62	82.51	105.62	94.47
Operating Profit (EBIT)	-98.40	-104.30	-64.54	-82.95	-105.62	-94.47
Other Income	--	--	--	--	--	-0.05
Profit before Tax	-18.14	-105.62	-119.76	-82.51	-105.58	-93.96
Provision for Tax	0.12	--	0.19	-0.82	-0.97	-0.94
Profit after Tax (Net Income)	-18.14	-105.62	-119.76	-82.51	-104.61	-93.02
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-105.58	-93.96

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-0.56	57.01	-17.15	4.06	62.54	81.94
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.03	2.39	0.80	0.88	0.89	1.33
Current Liabilities	32.90	27.30	71.18	33.42	26.46	21.24
Total Liabilities	67.28	86.69	54.83	38.36	89.89	104.51

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	2.72	3.05	0.45	1.06	1.50	1.91
Current Assets	31.65	83.65	54.39	37.31	88.39	102.59
Total Assets	67.28	86.69	54.83	38.36	89.89	104.51
Total Debt*	2.50	2.80	0.78	1.98	2.12	2.81
Net Current Assets	-1.25	56.35	-16.80	3.88	61.93	81.36

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-84.31	-55.17	-78.09	-90.73	-78.21
Cash Flow from Investing Activities	--	--	13.87	13.17	12.43	-19.47
Cash from Financing Activities	--	113.81	74.54	27.69	74.72	136.29
Net Cash Inflow / Outflow	--	--	--	--	--	38.62

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.11	-0.77	-1.42	-1.65	-4.00	-3.85
Cash EPS ($)	--	-0.77	-1.42	-1.64	-3.98	-3.84
Adjusted Book Value ($)	--	0.42	--	0.08	2.39	3.39
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.61	-0.65	-1.56	-3.47	-3.24
Free Cash Flow per Share ($)	--	-0.61	-0.65	-1.56	-3.47	-3.24

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-486.39	2,318.52	-233.41	-140.03	-155.82
ROE (%)	--	-529.97	1,830.54	-247.77	-144.82	-162.42
ROA (%)	-13.30	-149.27	-257.01	-128.66	-107.63	-121.68
EBIT Margin (%)	-10,073.57	-22,922.86	-645.80	-774.00	--	--
Net Margin (%)	-1,815.62	-23,214.07	-1,198.47	-774.00	--	172,262.96
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	573.46	-0.95	-0.06	--	--	--
EBIT Growth (%)	-9.05	-61.62	21.78	21.88	-11.81	-107.24
Net Profit Growth (%)	90.32	11.81	-45.15	21.13	-12.46	-104.91
EPS Growth (%)	93.16	0.46	0.14	0.59	-0.04	-0.77
Book Value Growth (%)	-109.44	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.11	-2.36	-0.46	-2.24	-5.71
Price / Book Value	7.72	2.06	-16.46	9.35	3.75	6.48
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-9.71	-0.39	-3.61	-0.11	-1.48	-4.65
Close Price ($)	0.60	0.86	3.35	0.76	8.95	22.01
High Price ($)	10.62	10.62	3.42	9.49	29.80	57.39
Low Price ($)	0.30	0.77	0.70	0.50	8.51	13.58
Market Cap ($ Cr)	14.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.05	-0.05	0.49	0.03	0.03
Short term debt to equity ratio	-0.83	0.01	-0.04	0.27	0.02	0.02
Current Ratio	0.96	3.06	0.76	1.12	3.34	4.83
Quick Ratio	0.96	--	0.72	0.96	3.36	4.86
Interest Coverage	--	--	--	-186.67	-190.30	-168.99

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	1,666.97	--	2.85	2.58	--	--
Asset Turnover	0.01	0.01	0.21	0.17	--	--
Receivable days	--	228.78	10.23	13.71	--	--
Inventory Days	--	24.60	29.15	1,986.51	-453.26	-485.40
Payable days	--	23.14	21.26	5,795.55	4,445.05	4,533.43
Cash Conversion Cycle	--	230.25	18.12	-3,795.33	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.